AIMCA
TNGX icon

Alberta Investment Management Corp (AIMCo)’s Tango Therapeutics TNGX Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio TNGX Stock Details TNGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-17,543
Closed -$64K – 1223
2022
Q3 		$64K Buy
+17,543
New +$74.9K ﹤0.01% 1191

Other funds holding TNGX

TGI
TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s TNGX Position: Q4 2022 in Review

Alberta Investment Management Corp (AIMCo) sold out of Tango Therapeutics (TNGX) in Q4 2022, closing a stake of 17,543 shares — an estimated $64K sold.

Alberta Investment Management Corp (AIMCo) first reported a position in TNGX in Q3 2022 and held it in 1 quarter. The position peaked at $64K in Q3 2022. 82 funds tracked by Wall St. Rank hold TNGX as of Q4 2022.

  • Alberta Investment Management Corp (AIMCo) reported no remaining Tango Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 17,543 Tango Therapeutics shares in Q4 2022, an estimated $64K.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Tango Therapeutics in Q3 2022 and held it in 1 quarter.
  • Alberta Investment Management Corp (AIMCo)'s Tango Therapeutics position peaked at $64K in Q3 2022.
  • 82 funds tracked by Wall St. Rank held Tango Therapeutics as of Q4 2022.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q4 2022, filed 14 Feb 2023.